Overview of the Market
The active pharmaceutical ingredient (API) is an important component in the pharmaceutical industry because it determines a drug’s efficacy and safety. The biologically active substance in a drug product that is responsible for the therapeutic effect is known as an API. To create the final drug product, the API is combined with excipients, which are inactive substances that act as a medium for the API. The API market is a rapidly expanding industry, driven by rising generic drug demand, rising chronic disease incidence, and technological advancements.
The global API market was worth USD 195.6 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 7.5% between 2021 and 2028. The rising prevalence of chronic diseases such as cancer, cardiovascular disease, and diabetes, as well as rising demand for generic drugs, are driving the growth of the API market. Additionally, rising R&D investment, technological advancements, and rising demand for specialty drugs are all contributing to the growth of the API market.
Visit this Page for More Information: Start a Business in API Industry
Segmentation of the Market
The API market is divided into three sections: product type, application, and geography.
- Depending on the Product Type
The API market is divided into three categories: synthetic APIs, biotech APIs, and hormones and peptides. Small molecules and macromolecules are sub-segments of the synthetic API segment. The synthetic API segment dominated the API market in 2020, and this dominance is expected to continue during the forecast period. This is due to the growing demand for generic drugs, the abundance of synthetic APIs on the market, and their lower cost when compared to biotech APIs.
- Depending on the Application
The API market is divided into several categories, including cardiovascular diseases, oncology, central nervous system disorders, respiratory diseases, and others. Because of the rising prevalence of cardiovascular diseases such as hypertension and coronary artery disease, as well as the rising demand for cardiovascular drugs, the cardiovascular disease segment dominated the API market in 2020.
Read our Books Here: Handbook on Active Pharmaceutical Ingredients (API), Drugs & Pharmaceutical Products
- Geographically
North America, Europe, Asia-Pacific, and the Rest of the World make up the API market. Because of the presence of a large number of pharmaceutical and biotechnology companies, a developed healthcare infrastructure, and rising demand for generic drugs, North America dominated the API market in 2020. The Asia-Pacific region is expected to grow at the fastest rate during the forecast period, owing to rising chronic disease prevalence, increased demand for generic drugs, and increased investment in the region’s pharmaceutical industry.
Important Players
The API market is highly fragmented, with numerous domestic and international players. Pfizer Inc., Merck & Co., Inc., Sanofi S.A., Novartis AG, GlaxoSmithKline plc, AstraZeneca plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., and Mylan N.V. are some of the key players in the API market. These companies are concentrating on strategic initiatives such as mergers and acquisitions, collaborations, and partnerships to broaden their product portfolios and increase their market share.
Market Trends
- Drivers
Chronic Disease Prevalence: The rising prevalence of chronic diseases such as cancer, cardiovascular disease, and diabetes is propelling the API market forward. API demand is being driven by the increasing demand for drugs to treat these diseases.
Growing Demand for Generic Drugs: The growing demand for generic drugs is propelling the API market forward. The rising popularity of generic drugs, which are less expensive than branded drugs, is driving up demand for APIs. Furthermore, rising healthcare costs and the expiration of patents on several branded drugs are driving demand for generic drugs and APIs.
Related Feasibility Study Reports: Active Pharmaceutical Ingredient (API) Products, Bulk API Manufacturing
Technological advancements, such as biotechnology and synthetic chemistry, are driving the growth of the API market. The development of new API synthesis technologies enables the development of new drugs, which drives API demand.
Increasing Investment in R&D: The pharmaceutical industry’s increasing investment in R&D is driving the growth of the API market. The investment in R&D enables the development of new drugs, which drives the demand for APIs.
- Restraints
Stringent Regulatory Requirements: The stringent regulatory requirements for the approval of APIs and drugs are a major impediment to the growth of the API market. API manufacturers face a significant challenge due to the lengthy and complex approval process, as well as the high cost of compliance.
Intellectual Property Issues: Intellectual property issues are a major impediment to the growth of the API market. The protection of intellectual property rights, such as patents, is a significant challenge for API manufacturers. Furthermore, the growing number of generic drugs on the market puts intellectual property rights at risk.
- Opportunities
Growing Demand for Specialty Drugs: The growing demand for specialty drugs presents a significant opportunity for the API market to grow. The rising prevalence of chronic diseases such as cancer and cardiovascular disease is driving demand for specialty drugs, which in turn is driving demand for APIs.
Emerging Markets: Emerging markets such as Asia-Pacific and Latin America present significant opportunities for the growth of the API market. The rising prevalence of chronic diseases, rising demand for generic drugs, and rising investment in the pharmaceutical industry in these regions are driving demand for APIs.
However, the API market faces several challenges, including stringent regulatory requirements and intellectual property concerns. To sustain their growth in the API market, API manufacturers must focus on addressing these challenges and adapting to changing market conditions. The API market is expected to remain highly competitive, with a large number of players competing for market share. To expand their product portfolios and increase their market share, the key players in the API market are expected to focus on strategic initiatives such as mergers and acquisitions, collaborations, and partnerships.
To remain competitive in the API market, API manufacturers must focus on developing innovative and cost-effective APIs while adhering to regulatory requirements. API manufacturers must also focus on expanding their presence in emerging markets and investing in research and development to develop new drugs and APIs.
However, the API market faces a number of challenges, including stringent regulatory requirements, intellectual property concerns, and increased competition. To remain competitive in the API market, API manufacturers must focus on developing innovative and cost-effective APIs while adhering to regulatory requirements. They must also focus on expanding their presence in emerging markets and investing in research and development to develop new drugs and APIs.
Conclusion
The API market is a rapidly expanding industry, driven by rising generic drug demand, rising chronic disease incidence, and technological advancements. The API market is highly fragmented, with numerous domestic and international players. To expand their product portfolios and increase their market share, the API market’s key players are focusing on strategic initiatives such as mergers and acquisitions, collaborations, and partnerships. The rising prevalence of chronic diseases, rising demand for generic drugs, and technological advancements are the primary drivers of the API market. However, the API market’s growth is hampered by stringent regulatory requirements and intellectual property concerns. The growing demand for specialty drugs, as well as emerging markets, present significant opportunities for the API market to grow.
Visit the page Select and Choose the Right Business Startup for You for sorting out the questions arising in your mind before starting any business and know which start-up you can plan.
We, at NPCS, endeavor to make business selection a simple and convenient step for any entrepreneur/startup. Our expert team, by capitalizing on its dexterity and decade’s long experience in the field, has created a list of profitable ventures for entrepreneurs who wish to diversify or venture. The list so mentioned is updated regularly to give you a regular dose of new emerging opportunities.
Click here to send your queries/Contact Us
Reasons for Buying NIIR Report:
- Our research report helps you get a detailed picture of the industry by providing an overview of the industry along with the market structure and classification.
- Our report provides market analysis covering major growth driving factors for the industry, the latest market trends and the regulatory framework of the industry.
- Our Report provides an analysis and in-depth financial comparison of major Players / Competitors.
- Our Report provides indispensable buyers' data with their company financials as well as the contact details, which can be an important tool in identifying the target customers.
- Our report provides forecasts of key parameters which help to anticipate the industry performance.
- We use reliable sources of information and databases. And information from such sources is processed by us and included in the report.
See More Links:
- Start a Business in Asia
- Start a Business in Potential Countries for Doing Business
- Best Industry for Doing Business
- Business Ideas with Low, Medium & High Investment
- Looking for Most Demandable Business Ideas for Startups
- Startup Consulting Services
- Start a Business in Africa
- Start a Business in India
- Start a Business in Middle East
- Related Videos
- Related Books
- Related Projects
- Related Market Research Reports
𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐮𝐬
NIIR PROJECT CONSULTANCY SERVICES, DELHI
An ISO 9001:2015 Company
ENTREPRENEUR INDIA
106-E, Kamla Nagar, Opp. Mall ST,
New Delhi-110007, India.
Email: npcs.ei@gmail.com
Tel: +91-11-23843955, 23845654, 23845886
Mobile: +91-9097075054, 8800733955
Website: https://www.entrepreneurindia.co
OF_20Art23